Redefining the Viral Reservoirs that Prevent HIV-1 Eradication

被引:378
作者
Eisele, Evelyn [1 ,2 ]
Siliciano, Robert F. [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; COMBINATION ANTIRETROVIRAL THERAPY; LOW-LEVEL VIREMIA; IN-VIVO; LATENT RESERVOIR; RESIDUAL HIV-1; INTRINSIC STABILITY; ONGOING REPLICATION; CHEMOKINE RECEPTOR;
D O I
10.1016/j.immuni.2012.08.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This Perspective proposes definitions for key terms in the field of HIV-1 latency and eradication. In the context of eradication, a reservoir is a cell type that allows persistence of replication-competent HIV-1 on a timescale of years in patients on optimal antiretroviral therapy. Reservoirs act as a barrier to eradication in the patient population in which cure attempts will likely be made. Halting viral replication is essential to eradication, and definitions and criteria for assessing whether this goal has been achieved are proposed. The cell types that may serve as reservoirs for HIV-1 are discussed. Currently, only latently infected resting CD4(+) T cells fit the proposed definition of a reservoir, and more evidence is necessary to demonstrate that other cell types, including hematopoietic stem cells and macrophages, fit this definition. Further research is urgently required on potential reservoirs in the gut-associated lymphoid tissue and the central nervous system.
引用
收藏
页码:377 / 388
页数:12
相关论文
共 139 条
[1]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[2]   Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells [J].
Anderson, Jeffrey A. ;
Archin, Nancie M. ;
Ince, William ;
Parker, Daniel ;
Wiegand, Ann ;
Coffin, John M. ;
Kuruc, Joann ;
Eron, Joseph ;
Swanstrom, Ronald ;
Margolis, David M. .
JOURNAL OF VIROLOGY, 2011, 85 (10) :5220-5223
[3]   Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid [J].
Archin, Nancie M. ;
Espeseth, Amy ;
Parker, Daniel ;
Cheema, Manzoor ;
Hazuda, Daria ;
Margolis, David M. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) :207-212
[4]   Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1 [J].
Arfi, Vanessa ;
Riviere, Lise ;
Jarrosson-Wuilleme, Loraine ;
Goujon, Caroline ;
Rigal, Dontinique ;
Darlix, Jean-Luc ;
Cimarelli, Andrea .
JOURNAL OF VIROLOGY, 2008, 82 (13) :6557-6565
[5]   Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells [J].
Auffray, Cedric ;
Sieweke, Michael H. ;
Geissmann, Frederic .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :669-692
[6]   The Male Genital Tract Is Not a Pharmacological Sanctuary From Efavirenz [J].
Avery, L. B. ;
Bakshi, R. P. ;
Cao, Y. J. ;
Hendrix, C. W. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (01) :151-156
[7]   Role of microglial cells in selective replication of Simian immunodeficiency virus genotypes in the brain [J].
Babas, T ;
Muñoz, D ;
Mankowski, JL ;
Tarwater, PA ;
Clements, JE ;
Zink, MC .
JOURNAL OF VIROLOGY, 2003, 77 (01) :208-216
[8]   Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells [J].
Bailey, JR ;
Sedaghat, AR ;
Kieffer, T ;
Brennan, T ;
Lee, PK ;
Wind-Rotolo, M ;
Haggerty, CM ;
Kamireddi, AR ;
Liu, Y ;
Lee, J ;
Persaud, D ;
Gallant, JE ;
Cofrancesco, J ;
Quinn, TC ;
Wilke, CO ;
Ray, SC ;
Siliciano, JD ;
Nettles, RE ;
Siliciano, RF .
JOURNAL OF VIROLOGY, 2006, 80 (13) :6441-6457
[9]   Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations [J].
Bailey, Justin R. ;
Williams, Thomas M. ;
Siliciano, Robert F. ;
Blankson, Joel N. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) :1357-1369
[10]   Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action [J].
Bazzoli, Caroline ;
Jullien, Vincent ;
Le Tiec, Clotilde ;
Rey, Elisabeth ;
Mentre, France ;
Taburet, Anne-Marie .
CLINICAL PHARMACOKINETICS, 2010, 49 (01) :17-45